Evidence map›Paper›PMID 42632850›Full record

ArticleBlood cancer journal2026

Prognostic impact of lymphocyte kinetics and immune composition during bispecific antibody therapy in relapsed/refractory multiple myeloma.

Mansi R Shah, Aishee Bag, Asis Shrestha, Yetunde Ogunsesan, Anup Trikannad, Sruthi Vellanki, Sanjay Muttineni, Hira Cheema, Syed Naqvi, Sasya Dronavalli and 8 more

Abstract readLetter
In one paragraph

Article in Blood cancer journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Mansi R ShahDivision of Blood Disorders, Rutgers Cancer Institute, New Brunswick, NJ, USA. shahmr@rutgers.edu.ORCID http://orcid.org/0000-0001-8884-3085
Aishee BagDepartment of Internal Medicine, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ, USA.ORCID http://orcid.org/0000-0001-9148-2380
Asis ShresthaUniversity of Arkansas for Medical Sciences, Myeloma Center, Little Rock, AR, USA.
Yetunde OgunsesanDivision of Hematology Oncology, Medical College of Wisconsin, Milwaukee, WI, USA.
Anup TrikannadUniversity of Arkansas for Medical Sciences, Myeloma Center, Little Rock, AR, USA.
Sruthi VellankiUniversity of Arkansas for Medical Sciences, Myeloma Center, Little Rock, AR, USA.
Sanjay MuttineniUniversity of Arkansas for Medical Sciences, Myeloma Center, Little Rock, AR, USA.
Hira CheemaUniversity of Arkansas for Medical Sciences, Myeloma Center, Little Rock, AR, USA.
Syed NaqviUniversity of Arkansas for Medical Sciences, Myeloma Center, Little Rock, AR, USA.
Sasya DronavalliUniversity of Arkansas for Medical Sciences, Myeloma Center, Little Rock, AR, USA.ORCID http://orcid.org/0009-0004-5523-010X
Samer Al HadidiMyeloma, Waldenstrom's, and Amyloidosis Program, Simmons Comprehensive Cancer Center, UT Southwestern Medical Center, Dallas, TX, USA.ORCID http://orcid.org/0000-0003-4297-8042
Sharmilan ThanendrarjanUniversity of Arkansas for Medical Sciences, Myeloma Center, Little Rock, AR, USA.
Maurizio ZangariUniversity of Arkansas for Medical Sciences, Myeloma Center, Little Rock, AR, USA.
Frits van RheeUniversity of Arkansas for Medical Sciences, Myeloma Center, Little Rock, AR, USA.ORCID http://orcid.org/0000-0001-9959-1282
Aniko SzaboDivision of Biostatistics, Data Science Institute, Medical College of Wisconsin, Milwaukee, WI, USA.ORCID http://orcid.org/0000-0002-8129-0614
Rajshekar ChakrabortyDivision of Division of Hematology Oncology, Columbia University Irving Medical Center, New York, NY, USA.ORCID http://orcid.org/0000-0001-7336-3003
Meera MohanDivision of Lymphoma and Myeloma, University of Texas MD Anderson Cancer, Houston, TX, USA.
Carolina SchinkeUniversity of Arkansas for Medical Sciences, Myeloma Center, Little Rock, AR, USA. cdschinke@uams.edu.ORCID http://orcid.org/0000-0002-2699-1741

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID42632850
PMCPMC13499802

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.